Nectome
Nectome offers a verifiable cryopreservation protocol designed to preserve the human body and brain at the end of life, with the goal of maintaining sufficient biological detail for potential future revival. The service is positioned as a last experimental option for terminally ill individuals, grounded in existing clinical literature and capable of preserving a person for hundreds of years.
- Biotechnology
- Healthcare Technology
Funding
Funding not disclosed
Founders
Founder details are not available yet.
Product
Problem
For people at the end of their lives, the possibility of future recovery or revival is lost once biological processes cease. No current medical option exists to preserve the body and brain in sufficient detail to allow for potential future reanimation or biological restoration.
Solution
Nectome provides a verifiable cryopreservation protocol designed to preserve the human body and brain at the end of life. The company claims its approach can preserve an individual for hundreds of years in sufficient detail that revival becomes a theoretical possibility in the long term. The protocol is positioned as a last experimental option for those nearing death, offering a life-affirming expression of the will to endure. The service is grounded in the canon of scientific and clinical literature that supports the underlying preservation methodology.
Target Audience
Primary customers are individuals at the end of their lives who wish to preserve their body and brain as a last experimental option for potential future revival.
Features
- Verifiable cryopreservation protocol specifically developed for human body and brain preservation
- Long-term preservation capabilities designed for hundreds of years
- Scientific grounding in existing clinical literature for preservation methodology
- End-of-life service offering for individuals seeking future revival possibility